Asciminib maintains antibody-dependent cellular cytotoxicity against leukemic blasts.

Holzmayer SJ, Kauer J, Mauermann J, Roider T, Märklin M

Cancers, 2024

doi:10.3390/cancers16071288.

Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities.

Roider T, Baertsch MA, Fitzgerald D, Vöhringer H, Brinkmann BJ, Czernilofsky F, Knoll M, Llaó-Cid L, Mathioudaki A, Faßbender B, Herbon M, Lautwein T, Bruch PM, Liebers N, Schürch CM, Passerini V, Seifert M, Brobeil A, Mechtersheimer G, Müller-Tidow C, Weigert O, Seiffert M, Nolan GP, Huber W, Dietrich S

Nature cell biology, 2024

doi:10.1038/s41556-024-01358-2.

A single-cell multi-omic and spatial atlas of B cell lymphomas reveals differentiation drives intratumor heterogeneity.

Fitzgerald D, Roider T, Baertsch M, Kibler A, Horlova A, Chung E, Vöhringer H, Mathioudaki A, Budeus B, Passerini V, Knoll M, Mammen J, Li L, Caillé L, Czernilofsky F, Bruch P, Liebers N, Meyer-Bender M, Weigert O, Zaugg J, Nolan G, Seifert M, Dietrich S, Huber W

bioRxiv, 2023

doi:10.1101/2023.11.06.565756.

Comparing the value of mono- versus coculture for high-throughput compound screening in hematological malignancies.

Herbst SA, Kim V, Roider T, Schitter EC, Bruch PM, Liebers N, Kolb C, Knoll M, Lu J, Dreger P, Müller-Tidow C, Zenz T, Huber W, Dietrich S

Blood advances, 2023

doi:10.1182/bloodadvances.2022009652.

Functional analysis of structural variants in single cells using Strand-seq.

Jeong H, Grimes K, Rauwolf KK, Bruch PM, Rausch T, Hasenfeld P, Benito E, Roider T, Sabarinathan R, Porubsky D, Herbst SA, Erarslan-Uysal B, Jann JC, Marschall T, Nowak D, Bourquin JP, Kulozik AE, Dietrich S, Bornhauser B, Sanders AD, Korbel JO

Nature biotechnology, 2022

doi:10.1038/s41587-022-01551-4.

Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.

Herbst SA, Vesterlund M, Helmboldt AJ, Jafari R, Siavelis I, Stahl M, Schitter EC, Liebers N, Brinkmann BJ, Czernilofsky F, Roider T, Bruch PM, Iskar M, Kittai A, Huang Y, Lu J, Richter S, Mermelekas G, Umer HM, Knoll M, Kolb C, Lenze A, Cao X, Österholm C, Wahnschaffe L, Herling C, Scheinost S, Ganzinger M, Mansouri L, Kriegsmann K, Kriegsmann M, Anders S, Zapatka M, Del Poeta G, Zucchetto A, Bomben R, Gattei V, Dreger P, Woyach J, Herling M, Müller-Tidow C, Rosenquist R, Stilgenbauer S, Zenz T, Huber W, Tausch E, Lehtiö J, Dietrich S

Nature communications, 2022

doi:10.1038/s41467-022-33385-8.

Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL.

Bruch PM, Giles HA, Kolb C, Herbst SA, Becirovic T, Roider T, Lu J, Scheinost S, Wagner L, Huellein J, Berest I, Kriegsmann M, Kriegsmann K, Zgorzelski C, Dreger P, Zaugg JB, Müller-Tidow C, Zenz T, Huber W, Dietrich S

Molecular systems biology, 2022

doi:10.15252/msb.202110855.

Processing human lymph node samples for single-cell assays.

Roider T, Brinkmann BJ, Dietrich S

STAR protocols, 2021

doi:10.1016/j.xpro.2021.100914.

Autologous culture model of nodal B-cell lymphoma identifies ex vivo determinants of response to bispecific antibodies.

Roider T, Brinkmann BJ, Kim V, Knoll M, Kolb C, Roessner PM, Bordas M, Dreger P, Müller-Tidow C, Huber W, Seiffert M, Dietrich S

Blood advances, 2021

doi:10.1182/bloodadvances.2021005400.

The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: an analysis of the MCL Younger and Elderly trial.

Roider T, Wang X, Hüttl K, Müller-Tidow C, Klapper W, Rosenwald A, Stewart JP, Gonzalez de Castro D, Dreger P, Hermine O, Kluin-Nelemans HC, Grabe N, Dreyling M, Pott C, Ott G, Hoster E, Dietrich S

International journal of cancer, 2020

doi:10.1002/ijc.33202.

Dissecting intratumour heterogeneity of nodal B-cell lymphomas at the transcriptional, genetic and drug-response levels.

Roider T, Seufert J, Uvarovskii A, Frauhammer F, Bordas M, Abedpour N, Stolarczyk M, Mallm JP, Herbst SA, Bruch PM, Balke-Want H, Hundemer M, Rippe K, Goeppert B, Seiffert M, Brors B, Mechtersheimer G, Zenz T, Peifer M, Chapuy B, Schlesner M, Müller-Tidow C, Fröhling S, Huber W, Anders S, Dietrich S

Nature cell biology, 2020

doi:10.1038/s41556-020-0532-x.

BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials.

Liebers N, Roider T, Bohn JP, Haberbosch I, Pircher A, Ferstl B, Ebnöther M, Wendtner CM, Dearden C, Follows GA, Ho AD, Müller-Tidow C, Dreger P, Troussard X, Zenz T, Dietrich S

Leukemia, 2019

doi:10.1038/s41375-019-0646-y.